A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.

MLA

Rasche, Leo, et al. “A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 22, no. 17, Sept. 2016, pp. 4341–49. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-15-3111.

APA

Rasche, L., Menoret, E., Dubljevic, V., Menu, E., Vanderkerken, K., Lapa, C., Steinbrunn, T., Chatterjee, M., Knop, S., Düll, J., Greenwood, D. L., Hensel, F., Rosenwald, A., Einsele, H., & Brändlein, S. (2016). A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(17), 4341–4349. https://doi.org/10.1158/1078-0432.CCR-15-3111

Chicago

Rasche, Leo, Emmanuelle Menoret, Valentina Dubljevic, Eline Menu, Karin Vanderkerken, Constantin Lapa, Torsten Steinbrunn, et al. 2016. “A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 22 (17): 4341–49. doi:10.1158/1078-0432.CCR-15-3111.